Back
Mackenzie Emerging Markets Equity Index ETF Vs. Aligos Therapeutics, Inc. Industry Stock Comparison
Sell
50
QEE.TO
Mackenzie Emerging Markets Equity Index ETF
Last Price:
$116.76
Seasonality Move:
2.21%
Buy
79
ALGS
Aligos Therapeutics, Inc.
Last Price:
$11.43
Seasonality Move:
-2.85%
Sell
50
Mackenzie Emerging Markets Equity Index ETF (QEE.TO)
is a Sell
Is Mackenzie Emerging Markets Equity Index ETF a Buy, Sell or Hold?
-
The current Mackenzie Emerging Markets Equity Index ETF [QEE.TO] share price is $117.84. The Score for QEE.TO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
QEE.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
79
Aligos Therapeutics, Inc. (ALGS)
is a Buy
Is Aligos Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Aligos Therapeutics, Inc. [ALGS] share price is $12.00. The Score for ALGS is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QEE.TO Stock Price Chart
What is Mackenzie Emerging Markets Equity Index ETF's stock price today?
-
The Mackenzie Emerging Markets Equity Index ETF share price today is $117.84Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QEE.TO is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics, Inc.'s stock price today?
-
The Aligos Therapeutics, Inc. share price today is $12.00The current trend is moderately bullish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.
QEE.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.47 | Sell |
| Relative Strength Index (14 RSI): | 38.01 | Sell |
| Chaikin Money Flow: | -515 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (118.62 - 121.3) | Sell |
| Bollinger Bands (100): | (110.3 - 121.44) | Buy |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.95 | Buy |
| Relative Strength Index (14 RSI): | 66.05 | Buy |
| Chaikin Money Flow: | -92908 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.35 - 11.09) | Buy |
| Bollinger Bands (100): | (7.91 - 10.73) | Buy |
QEE.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 119.21 | Sell |
| 20-day SMA: | 119.49 | Sell |
| 50-day SMA: | 120.5 | Sell |
| 200-day SMA: | 107.76 | Buy |
| 8-day EMA: | 119 | Sell |
| 20-day EMA: | 119.64 | Sell |
| 50-day EMA: | 119.09 | Sell |
| 200-day EMA: | 110.27 | Buy |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.26 | Buy |
| 20-day SMA: | 9.89 | Buy |
| 50-day SMA: | 9.21 | Buy |
| 200-day SMA: | 8.43 | Buy |
| 8-day EMA: | 11.4 | Buy |
| 20-day EMA: | 10.25 | Buy |
| 50-day EMA: | 9.51 | Buy |
| 200-day EMA: | 10.53 | Buy |
Mackenzie Emerging Markets Equity Index ETF Earnings Growth & QEE.TO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics, Inc. Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.41 per share, and a decrease next year of $0.26 per share.
Mackenzie Emerging Markets Equity Index ETF Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||